Date sample taken
Item
Date sample taken
date
C1302413 (UMLS CUI [1])
Item
Sample taken - not done
integer
C0200345 (UMLS CUI [1,1])
C1272696 (UMLS CUI [1,2])
Code List
Sample taken - not done
Haem Lab type code
Item
Haem Lab type code
text
C0018941 (UMLS CUI [1,1])
C0022877 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
Chem Lab type code
Item
Chem Lab type code
text
C0005774 (UMLS CUI [1,1])
C0022877 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
Urin Lab type code
Item
Urin Lab type code
text
C0042014 (UMLS CUI [1,1])
C0022877 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
Heart rate
Item
Heart rate
integer
C0018810 (UMLS CUI [1])
PR Interval
Item
PR Interval
integer
C0429087 (UMLS CUI [1])
QRS Duration
Item
QRS Duration
integer
C0429025 (UMLS CUI [1])
Uncorrected QT Interval
Item
Uncorrected QT Interval
integer
C1287082 (UMLS CUI [1])
Item
Method of QTc Calculation
text
C0855331 (UMLS CUI [1,1])
C2911685 (UMLS CUI [1,2])
Code List
Method of QTc Calculation
Record QTc value(s) generated by the machine - Bazett
Item
Record QTc value(s) generated by the machine - Bazett
integer
C1882512 (UMLS CUI [1,1])
C0855331 (UMLS CUI [1,2])
Record QTc value(s) generated by the machine - Fridericia
Item
Record QTc value(s) generated by the machine - Fridericia
integer
C1882513 (UMLS CUI [1,1])
C0855331 (UMLS CUI [1,2])
Item
Result of the ECG
text
C0438154 (UMLS CUI [1])
Code List
Result of the ECG
CL Item
Abnormal - Not clinically significant (2)
CL Item
Abnormal - Clinically significant (3)
CL Item
Sinus bradycardia (A1)
CL Item
Sinus tachycardia (heart rate >100 beats/min) (A2)
CL Item
Artrial fibrillation (A8)
CL Item
Right bundle branch block (C8)
CL Item
Left bundle branch block (C9)
CL Item
Myocardial infarction, old (D1)
CL Item
Other abnormalities (E99)
If other ECG result, enter comment
Item
If other ECG result, enter comment
text
C0438154 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
Neovascular AMD (wet) diagnosis
Item
Neovascular AMD (wet) diagnosis
boolean
C3888896 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
If neovascular AMD (wet) diagnosis, record date
Item
If neovascular AMD (wet) diagnosis, record date
date
C3888896 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,3])
Has the subject received any anti-VEGF intravitreal injections for the treatment of neovascular AMD?
Item
Has the subject received any anti-VEGF intravitreal injections for the treatment of neovascular AMD?
boolean
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C0242383 (UMLS CUI [2,1])
C4068891 (UMLS CUI [2,2])
Item
Which anti-VEGF intravitreal injections has the subject ever received?
integer
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
Code List
Which anti-VEGF intravitreal injections has the subject ever received?
CL Item
bevacizumab (Avastin) (1)
CL Item
pegaptanib (Macugen) (2)
CL Item
ranibizumab (Lucentis) (3)
CL Item
Other investigational product for CNV (19)
First anti-VEGF intravitreal treatment date
Item
First anti-VEGF intravitreal treatment date
date
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C3173309 (UMLS CUI [2])
Last anti-VEGF intravitreal treatment date
Item
Last anti-VEGF intravitreal treatment date
date
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C1531784 (UMLS CUI [1,3])
Item
Last anti-VEGF intravitreal treatment
text
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1517741 (UMLS CUI [2,2])
Code List
Last anti-VEGF intravitreal treatment
CL Item
Other investigational product for CNV (9)
CL Item
bevacizumab (Avastin) = bevacizumab (Avastin) (1)
CL Item
pegaptanib (Macugen) = pegaptanib (Macugen) (2)
CL Item
ranibizumab (Lucentis) = ranibizumab (Lucentis) (3)
Approximate total lifetime anti-VEGF intravitreal injections
Item
Approximate total lifetime anti-VEGF intravitreal injections
integer
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C1265611 (UMLS CUI [2,1])
C4071830 (UMLS CUI [2,2])
Total anti-VEGF intravitreal injections in the 6 months prior to the Screening Visit
Item
Total anti-VEGF intravitreal injections in the 6 months prior to the Screening Visit
integer
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C1265611 (UMLS CUI [2,1])
C0220908 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
Item
Has the subject received any other neovascular AMD treatments?
text
C0242383 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Code List
Has the subject received any other neovascular AMD treatments?
CL Item
Yes, select treatments (Y)
CL Item
photodynamic therapy with verteporfin (4)
CL Item
intravitreal steroids (5)
CL Item
Other investigational product for CNV (9)
CL Item
Other investigational devices for CNV (10)
Neovascular AMD (wet) diagnosis
Item
Neovascular AMD (wet) diagnosis
boolean
C3888896 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
If neovascular AMD (wet) diagnosis, record date
Item
If neovascular AMD (wet) diagnosis, record date
date
C3888896 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,3])
Has the subject received any anti-VEGF intravitreal injections for the treatment of neovascular AMD?
Item
Has the subject received any anti-VEGF intravitreal injections for the treatment of neovascular AMD?
boolean
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C0242383 (UMLS CUI [2,1])
C4068891 (UMLS CUI [2,2])
Item
Which anti-VEGF intravitreal injections has the subject ever received?
integer
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
Code List
Which anti-VEGF intravitreal injections has the subject ever received?
CL Item
bevacizumab (Avastin) (1)
CL Item
pegaptanib (Macugen) (2)
CL Item
ranibizumab (Lucentis) (3)
CL Item
Other investigational product for CNV (19)
First anti-VEGF intravitreal treatment date
Item
First anti-VEGF intravitreal treatment date
date
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C3173309 (UMLS CUI [2])
Last anti-VEGF intravitreal treatment date
Item
Last anti-VEGF intravitreal treatment date
date
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C1531784 (UMLS CUI [1,3])
Item
Last anti-VEGF intravitreal treatment
text
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1517741 (UMLS CUI [2,2])
Code List
Last anti-VEGF intravitreal treatment
CL Item
bevacizumab (Avastin) = bevacizumab (Avastin) (1)
CL Item
pegaptanib (Macugen) = pegaptanib (Macugen) (2)
CL Item
ranibizumab (Lucentis) = ranibizumab (Lucentis) (3)
CL Item
Other investigational product for CNV (9)
Approximate total lifetime anti-VEGF intravitreal injections
Item
Approximate total lifetime anti-VEGF intravitreal injections
integer
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C1265611 (UMLS CUI [2,1])
C4071830 (UMLS CUI [2,2])
Total anti-VEGF intravitreal injections in the 6 months prior to the Screening Visit
Item
Total anti-VEGF intravitreal injections in the 6 months prior to the Screening Visit
integer
C1554888 (UMLS CUI [1,1])
C0596087 (UMLS CUI [1,2])
C1265611 (UMLS CUI [2,1])
C0220908 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
Item
Has the subject received any other neovascular AMD treatments?
text
C0242383 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Code List
Has the subject received any other neovascular AMD treatments?
CL Item
Yes, select treatments (Y)
CL Item
photodynamic therapy with verteporfin (4)
CL Item
intravitreal steroids (5)
CL Item
Other investigational product for CNV (9)
CL Item
Other investigational devices for CNV (10)